The Genome Editing/Genome Engineering market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Genome Editing/Genome Engineering market size is estimated to be worth US$ 3614.8 million in 2021 and is forecast to a readjusted size of USD 6565.6 million by 2028 with a CAGR of 8.9% during review period. Cell Line Engineering accounting for % of the Genome Editing/Genome Engineering global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CRISPR segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genome Editing/Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, and Sangamo Biosciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genome Editing/Genome Engineering market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CRISPR
TALEN
ZFN
Market segment by Application, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genome Editing/Genome Engineering product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genome Editing/Genome Engineering, with revenue, gross margin and global market share of Genome Editing/Genome Engineering from 2019 to 2022.
Chapter 3, the Genome Editing/Genome Engineering competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genome Editing/Genome Engineering market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genome Editing/Genome Engineering research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Genome Editing/Genome Engineering
1.2 Classification of Genome Editing/Genome Engineering by Type
1.2.1 Overview: Global Genome Editing/Genome Engineering Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genome Editing/Genome Engineering Revenue Market Share by Type in 2021
1.2.3 CRISPR
1.2.4 TALEN
1.2.5 ZFN
1.3 Global Genome Editing/Genome Engineering Market by Application
1.3.1 Overview: Global Genome Editing/Genome Engineering Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.4 Global Genome Editing/Genome Engineering Market Size & Forecast
1.5 Global Genome Editing/Genome Engineering Market Size and Forecast by Region
1.5.1 Global Genome Editing/Genome Engineering Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genome Editing/Genome Engineering Market Size by Region, (2017-2022)
1.5.3 North America Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
1.5.4 Europe Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
1.5.6 South America Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genome Editing/Genome Engineering Market Drivers
1.6.2 Genome Editing/Genome Engineering Market Restraints
1.6.3 Genome Editing/Genome Engineering Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Genome Editing/Genome Engineering Product and Solutions
2.2.4 Merck Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 Horizon Discovery
2.3.1 Horizon Discovery Details
2.3.2 Horizon Discovery Major Business
2.3.3 Horizon Discovery Genome Editing/Genome Engineering Product and Solutions
2.3.4 Horizon Discovery Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Horizon Discovery Recent Developments and Future Plans
2.4 Genscript
2.4.1 Genscript Details
2.4.2 Genscript Major Business
2.4.3 Genscript Genome Editing/Genome Engineering Product and Solutions
2.4.4 Genscript Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Genscript Recent Developments and Future Plans
2.5 Sangamo Biosciences
2.5.1 Sangamo Biosciences Details
2.5.2 Sangamo Biosciences Major Business
2.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Product and Solutions
2.5.4 Sangamo Biosciences Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Sangamo Biosciences Recent Developments and Future Plans
2.6 Integrated Dna Technologies
2.6.1 Integrated Dna Technologies Details
2.6.2 Integrated Dna Technologies Major Business
2.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Product and Solutions
2.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Integrated Dna Technologies Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Genome Editing/Genome Engineering Product and Solutions
2.7.4 Lonza Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Lonza Recent Developments and Future Plans
2.8 New England Biolabs
2.8.1 New England Biolabs Details
2.8.2 New England Biolabs Major Business
2.8.3 New England Biolabs Genome Editing/Genome Engineering Product and Solutions
2.8.4 New England Biolabs Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 New England Biolabs Recent Developments and Future Plans
2.9 Origene Technologies
2.9.1 Origene Technologies Details
2.9.2 Origene Technologies Major Business
2.9.3 Origene Technologies Genome Editing/Genome Engineering Product and Solutions
2.9.4 Origene Technologies Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Origene Technologies Recent Developments and Future Plans
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business
2.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product and Solutions
2.10.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.11 Editas Medicine
2.11.1 Editas Medicine Details
2.11.2 Editas Medicine Major Business
2.11.3 Editas Medicine Genome Editing/Genome Engineering Product and Solutions
2.11.4 Editas Medicine Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Editas Medicine Recent Developments and Future Plans
2.12 Crispr Therapeutics
2.12.1 Crispr Therapeutics Details
2.12.2 Crispr Therapeutics Major Business
2.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Product and Solutions
2.12.4 Crispr Therapeutics Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Crispr Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Genome Editing/Genome Engineering Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genome Editing/Genome Engineering Players Market Share in 2021
3.2.2 Top 10 Genome Editing/Genome Engineering Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genome Editing/Genome Engineering Players Head Office, Products and Services Provided
3.4 Genome Editing/Genome Engineering Mergers & Acquisitions
3.5 Genome Editing/Genome Engineering New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Genome Editing/Genome Engineering Revenue and Market Share by Type (2017-2022)
4.2 Global Genome Editing/Genome Engineering Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Genome Editing/Genome Engineering Revenue Market Share by Application (2017-2022)
5.2 Global Genome Editing/Genome Engineering Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Genome Editing/Genome Engineering Revenue by Type (2017-2028)
6.2 North America Genome Editing/Genome Engineering Revenue by Application (2017-2028)
6.3 North America Genome Editing/Genome Engineering Market Size by Country
6.3.1 North America Genome Editing/Genome Engineering Revenue by Country (2017-2028)
6.3.2 United States Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
6.3.3 Canada Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
6.3.4 Mexico Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Genome Editing/Genome Engineering Revenue by Type (2017-2028)
7.2 Europe Genome Editing/Genome Engineering Revenue by Application (2017-2028)
7.3 Europe Genome Editing/Genome Engineering Market Size by Country
7.3.1 Europe Genome Editing/Genome Engineering Revenue by Country (2017-2028)
7.3.2 Germany Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7.3.3 France Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7.3.5 Russia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7.3.6 Italy Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genome Editing/Genome Engineering Revenue by Type (2017-2028)
8.2 Asia-Pacific Genome Editing/Genome Engineering Revenue by Application (2017-2028)
8.3 Asia-Pacific Genome Editing/Genome Engineering Market Size by Region
8.3.1 Asia-Pacific Genome Editing/Genome Engineering Revenue by Region (2017-2028)
8.3.2 China Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8.3.3 Japan Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8.3.4 South Korea Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8.3.5 India Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8.3.7 Australia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Genome Editing/Genome Engineering Revenue by Type (2017-2028)
9.2 South America Genome Editing/Genome Engineering Revenue by Application (2017-2028)
9.3 South America Genome Editing/Genome Engineering Market Size by Country
9.3.1 South America Genome Editing/Genome Engineering Revenue by Country (2017-2028)
9.3.2 Brazil Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
9.3.3 Argentina Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genome Editing/Genome Engineering Revenue by Type (2017-2028)
10.2 Middle East & Africa Genome Editing/Genome Engineering Revenue by Application (2017-2028)
10.3 Middle East & Africa Genome Editing/Genome Engineering Market Size by Country
10.3.1 Middle East & Africa Genome Editing/Genome Engineering Revenue by Country (2017-2028)
10.3.2 Turkey Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
10.3.4 UAE Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Genome Editing/Genome Engineering Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genome Editing/Genome Engineering Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genome Editing/Genome Engineering Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genome Editing/Genome Engineering Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genome Editing/Genome Engineering Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Genome Editing/Genome Engineering Product and Solutions
Table 9. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Genome Editing/Genome Engineering Product and Solutions
Table 13. Merck Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 15. Horizon Discovery Major Business
Table 16. Horizon Discovery Genome Editing/Genome Engineering Product and Solutions
Table 17. Horizon Discovery Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Genscript Corporate Information, Head Office, and Major Competitors
Table 19. Genscript Major Business
Table 20. Genscript Genome Editing/Genome Engineering Product and Solutions
Table 21. Genscript Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Sangamo Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Sangamo Biosciences Major Business
Table 24. Sangamo Biosciences Genome Editing/Genome Engineering Product and Solutions
Table 25. Sangamo Biosciences Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Integrated Dna Technologies Corporate Information, Head Office, and Major Competitors
Table 27. Integrated Dna Technologies Major Business
Table 28. Integrated Dna Technologies Genome Editing/Genome Engineering Product and Solutions
Table 29. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Lonza Corporate Information, Head Office, and Major Competitors
Table 31. Lonza Major Business
Table 32. Lonza Genome Editing/Genome Engineering Product and Solutions
Table 33. Lonza Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 35. New England Biolabs Major Business
Table 36. New England Biolabs Genome Editing/Genome Engineering Product and Solutions
Table 37. New England Biolabs Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Origene Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Origene Technologies Major Business
Table 40. Origene Technologies Genome Editing/Genome Engineering Product and Solutions
Table 41. Origene Technologies Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Transposagen Biopharmaceuticals Major Business
Table 44. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product and Solutions
Table 45. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 47. Editas Medicine Major Business
Table 48. Editas Medicine Genome Editing/Genome Engineering Product and Solutions
Table 49. Editas Medicine Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Crispr Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Crispr Therapeutics Major Business
Table 52. Crispr Therapeutics Genome Editing/Genome Engineering Product and Solutions
Table 53. Crispr Therapeutics Genome Editing/Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Genome Editing/Genome Engineering Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Genome Editing/Genome Engineering Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Genome Editing/Genome Engineering by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Genome Editing/Genome Engineering Players Head Office, Products and Services Provided
Table 58. Genome Editing/Genome Engineering Mergers & Acquisitions in the Past Five Years
Table 59. Genome Editing/Genome Engineering New Entrants and Expansion Plans
Table 60. Global Genome Editing/Genome Engineering Revenue (USD Million) by Type (2017-2022)
Table 61. Global Genome Editing/Genome Engineering Revenue Share by Type (2017-2022)
Table 62. Global Genome Editing/Genome Engineering Revenue Forecast by Type (2023-2028)
Table 63. Global Genome Editing/Genome Engineering Revenue by Application (2017-2022)
Table 64. Global Genome Editing/Genome Engineering Revenue Forecast by Application (2023-2028)
Table 65. North America Genome Editing/Genome Engineering Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Genome Editing/Genome Engineering Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Genome Editing/Genome Engineering Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Genome Editing/Genome Engineering Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Genome Editing/Genome Engineering Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Genome Editing/Genome Engineering Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Genome Editing/Genome Engineering Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Genome Editing/Genome Engineering Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Genome Editing/Genome Engineering Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Genome Editing/Genome Engineering Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Genome Editing/Genome Engineering Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Genome Editing/Genome Engineering Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Genome Editing/Genome Engineering Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Genome Editing/Genome Engineering Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Genome Editing/Genome Engineering Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Genome Editing/Genome Engineering Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Genome Editing/Genome Engineering Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Genome Editing/Genome Engineering Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Genome Editing/Genome Engineering Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Genome Editing/Genome Engineering Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Genome Editing/Genome Engineering Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Genome Editing/Genome Engineering Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Genome Editing/Genome Engineering Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Genome Editing/Genome Engineering Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Genome Editing/Genome Engineering Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Genome Editing/Genome Engineering Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Genome Editing/Genome Engineering Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Genome Editing/Genome Engineering Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Genome Editing/Genome Engineering Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Genome Editing/Genome Engineering Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Genome Editing/Genome Engineering Picture
Figure 2. Global Genome Editing/Genome Engineering Revenue Market Share by Type in 2021
Figure 3. CRISPR
Figure 4. TALEN
Figure 5. ZFN
Figure 6. Genome Editing/Genome Engineering Revenue Market Share by Application in 2021
Figure 7. Cell Line Engineering Picture
Figure 8. Animal Genetic Engineering Picture
Figure 9. Plant Genetic Engineering Picture
Figure 10. Global Genome Editing/Genome Engineering Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Genome Editing/Genome Engineering Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Genome Editing/Genome Engineering Revenue Market Share by Region (2017-2028)
Figure 13. Global Genome Editing/Genome Engineering Revenue Market Share by Region in 2021
Figure 14. North America Genome Editing/Genome Engineering Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Genome Editing/Genome Engineering Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Genome Editing/Genome Engineering Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Genome Editing/Genome Engineering Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Genome Editing/Genome Engineering Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Genome Editing/Genome Engineering Market Drivers
Figure 20. Genome Editing/Genome Engineering Market Restraints
Figure 21. Genome Editing/Genome Engineering Market Trends
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Horizon Discovery Recent Developments and Future Plans
Figure 25. Genscript Recent Developments and Future Plans
Figure 26. Sangamo Biosciences Recent Developments and Future Plans
Figure 27. Integrated Dna Technologies Recent Developments and Future Plans
Figure 28. Lonza Recent Developments and Future Plans
Figure 29. New England Biolabs Recent Developments and Future Plans
Figure 30. Origene Technologies Recent Developments and Future Plans
Figure 31. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 32. Editas Medicine Recent Developments and Future Plans
Figure 33. Crispr Therapeutics Recent Developments and Future Plans
Figure 34. Global Genome Editing/Genome Engineering Revenue Share by Players in 2021
Figure 35. Genome Editing/Genome Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Genome Editing/Genome Engineering Revenue Market Share in 2021
Figure 37. Global Top 10 Players Genome Editing/Genome Engineering Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Genome Editing/Genome Engineering Revenue Share by Type in 2021
Figure 40. Global Genome Editing/Genome Engineering Market Share Forecast by Type (2023-2028)
Figure 41. Global Genome Editing/Genome Engineering Revenue Share by Application in 2021
Figure 42. Global Genome Editing/Genome Engineering Market Share Forecast by Application (2023-2028)
Figure 43. North America Genome Editing/Genome Engineering Sales Market Share by Type (2017-2028)
Figure 44. North America Genome Editing/Genome Engineering Sales Market Share by Application (2017-2028)
Figure 45. North America Genome Editing/Genome Engineering Revenue Market Share by Country (2017-2028)
Figure 46. United States Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Genome Editing/Genome Engineering Sales Market Share by Type (2017-2028)
Figure 50. Europe Genome Editing/Genome Engineering Sales Market Share by Application (2017-2028)
Figure 51. Europe Genome Editing/Genome Engineering Revenue Market Share by Country (2017-2028)
Figure 52. Germany Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Genome Editing/Genome Engineering Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Genome Editing/Genome Engineering Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Genome Editing/Genome Engineering Revenue Market Share by Region (2017-2028)
Figure 60. China Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Genome Editing/Genome Engineering Sales Market Share by Type (2017-2028)
Figure 67. South America Genome Editing/Genome Engineering Sales Market Share by Application (2017-2028)
Figure 68. South America Genome Editing/Genome Engineering Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Genome Editing/Genome Engineering Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Genome Editing/Genome Engineering Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Genome Editing/Genome Engineering Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Genome Editing/Genome Engineering Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source